ExodusPoint Capital Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,170,745
| Closed | -$3.9M | – | 1624 |
|
|
2025
Q1 | $3.9M | Buy |
+1,170,745
| New | +$3.9M | 0.04% | 460 |
|
|
2023
Q4 | – | Sell |
-98,663
| Closed | -$449K | – | 1673 |
|
|
2023
Q3 | $449K | Sell |
98,663
-351,237
| -78% | -$1.6M | ﹤0.01% | 1239 |
|
|
2023
Q2 | $3.17M | Buy |
+449,900
| New | +$3.17M | 0.03% | 545 |
|
|
2023
Q1 | – | Sell |
-253,733
| Closed | -$1.62M | – | 1838 |
|
|
2022
Q4 | $1.62M | Buy |
253,733
+183,354
| +261% | +$1.17M | 0.02% | 720 |
|
|
2022
Q3 | $674K | Sell |
70,379
-29,400
| -29% | -$282K | 0.01% | 1234 |
|
|
2022
Q2 | $1.1M | Sell |
99,779
-38,576
| -28% | -$426K | 0.01% | 993 |
|
|
2022
Q1 | $2.3M | Buy |
138,355
+122,876
| +794% | +$2.05M | 0.03% | 660 |
|
|
2021
Q4 | $295K | Sell |
15,479
-14,275
| -48% | -$272K | ﹤0.01% | 1627 |
|
|
2021
Q3 | $734K | Sell |
29,754
-22,898
| -43% | -$565K | 0.01% | 1139 |
|
|
2021
Q2 | $1.37M | Buy |
+52,652
| New | +$1.37M | 0.02% | 787 |
|
|
2021
Q1 | – | Sell |
-45,671
| Closed | -$2.12M | – | 2275 |
|
|
2020
Q4 | $2.12M | Buy |
45,671
+30,495
| +201% | +$1.41M | 0.02% | 488 |
|
|
2020
Q3 | $500K | Sell |
15,176
-71,744
| -83% | -$2.36M | 0.01% | 962 |
|
|
2020
Q2 | $2.39M | Buy |
+86,920
| New | +$2.39M | 0.06% | 345 |
|